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ABSTRACT
Background. We examined whether there are genetic inﬂuences on nicotine withdrawal, and
whether there are genetic factors speciﬁc to nicotine withdrawal, after controlling for factors
responsible for risk of progression beyond experimentation with cigarettes and for quantity smoked
(average number of cigarettes per day at peak lifetime use).
Method. Epidemiologic and genetic analyses were conducted using telephone diagnostic interview
data from young adult Australian twins reporting any cigarette use (3026 women, 2553 men; mean
age 30 years).
Results. Genetic analysis of the eight symptoms of DSM-IV nicotine withdrawal suggests herita-
bility is intermediate for most symptoms (26–43%), and similar in men and women. The exceptions
were depressed mood upon withdrawal, which had stronger additive genetic inﬂuences in men
(53%) compared to women (29%), and decreased heart rate, which had low heritability (9%).
Although prevalence rates were substantially lower for DSM-IV nicotine withdrawal syndrome
(15.9%), which requires impairment, than for the DSM-IV nicotine dependence withdrawal
criterion (43.6%), heritability was similar for both measures : as high as 47%. Genetic modeling of
smoking more than 1 or 2 cigarettes lifetime (‘progression’), quantity smoked and nicotine with-
drawal found signiﬁcant genetic overlap across all three components of nicotine use/dependence
(genetic correlations=0.53–0.76). Controlling for factors associated with risk of cigarette smoking
beyond experimentation and quantity smoked, evidence for genetic inﬂuences speciﬁc to nicotine
withdrawal (up to 23% of total variance) remained.
Conclusions. Our results suggest that at least some individuals become ‘hooked’ or progress in the
smoking habit, in part, because of a vulnerability to nicotine withdrawal.
INTRODUCTION
Cigarette smoking remains the single greatest
preventable cause of death in the USA (CDC,
2005a), and severity of nicotine withdrawal
(NW) symptoms is believed to contribute to
smoking cessation failure (Cummings et al.
1985a, b ; West et al. 1989; Carmody, 1992;
Shiﬀman et al. 1997; Piasecki et al. 1998, 2000,
2003). Gaining a greater understanding of both
phenotypic and genetic characteristics of NW
may be useful in decreasing morbidity and
mortality in heavily dependent and relapsing
smokers, if ﬁndings can be successfully applied
to smoking-cessation interventions. Genetic
inﬂuences play an important role in initiation of
smoking (Heath et al. 1993; Heath & Madden,
1995; Li et al. 2003; Madden et al. 2004) and
an even greater role in persistence of smoking
(Heath & Madden, 1995; Madden et al. 1999)
and nicotine dependence (Kendler et al. 1999;
True et al. 1999; Lessov et al. 2004; Maes et al.
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2004). Heritability estimates for smoking per-
sistence range from 53% to 71% (Kaprio &
Koskenvuo, 1988; Heath&Martin, 1993;Heath
& Madden, 1995), and for nicotine dependence
range from 56% to 72% (Kendler et al. 1999;
True et al. 1999; Lessov et al. 2004; Maes et al.
2004). Withdrawal plays a central role in some
theories of dependence (e.g. the dependence
syndrome conceptualized by Edwards & Gross,
1976; Shiﬀman et al. 2004). Genetic research on
risk for withdrawal symptoms on cigarette
reduction can address the extent to which diﬀer-
ences in withdrawal vulnerability are potential
mediators of the powerful genetic inﬂuences
that have previously been reported for other
components of smoking behavior (Heath et al.
1993; Heath & Madden, 1995; Madden et al.
1999; Li et al. 2003; Madden et al. 2004).
In an eﬀort to reﬁne the phenotype of NW,
Madden et al. (1997) examined lifetime NW in a
survey of an older Australian cohort of adult
female twins. Using latent class analysis they
found three NW severity classes. However, they
did not have adequate power to test for genetic
inﬂuences on the latent classes. Similar pheno-
typic results were recently found using the
Vietnam Era Twin Registry (Xian et al. 2005).
In addition, in this population of male twins,
Xian and colleagues (2003, 2005) reported sig-
niﬁcant genetic inﬂuences on NW, viewed as
continuous factor scores (29.7% heritability in
regular smokers) or as latent classes (31%). In
addition, a modest genetic correlation between
withdrawal and failed cessation (rA=0.31–0.37)
was found (Xian et al. 2003, 2005). One limi-
tation of this study was that the analyses
excluded pairs where both twins did not try to
quit cigarettes. Multivariate genetic analyses of
nicotine-dependence symptoms in a young adult
Australian twin cohort (Lessov et al. 2004) have
also provided evidence for signiﬁcant genetic
variance in NW vulnerability (53% heritability
in ever smokers), and demonstrated that most,
but not all, genetic risk contributing to the
onset of NW was shared with other nicotine-
dependence symptoms.
Important areas of uncertainty remain con-
cerning the genetics of NW vulnerability. At the
most basic level, there have been no reports of
the heritability of individual symptoms of NW.
Also unclear is the degree of genetic overlap
between the initiation of regular cigarette
smoking and NW vulnerability. Given the
evidence for genetic inﬂuences on the initiation
of smoking (Heath et al. 1993; Heath &
Madden, 1995; Li et al. 2003; Madden et al.
2004), various models, with varying limitations
(e.g. Heath et al. 2002), have been used to
examine the overlap of genetic inﬂuences on
initiation of smoking, and genetic inﬂuences on
outcome measures including persistence of
smoking (Eaves & Eysenck, 1980; Heath, 1990;
Heath & Martin, 1993; Madden et al. 1999;
Heath et al. 2002), quantity smoked (Koopmans
et al. 1999), and nicotine dependence (Kendler
et al. 1999; Maes et al. 2004), but these methods
have not been applied to the case of NW.
Our goals in this paper were, therefore, to
examine in both women andmen: (1) genetic and
environmental inﬂuences on individual DSM-
IV symptoms, DSM-IV withdrawal criteria
for nicotine dependence, and DSM-IV-deﬁned
nicotine withdrawal syndrome (NWS), and (2)
the extent to which the same genetic and
environmental factors underlie the transitions
from smoking beyond experimentation with




The 1989 Australian Adult Twin Cohort
Participants were male and female twins born
1964–1971 from the Australian Twin Registry
who were ﬁrst surveyed by mailed questionnaire
in 1989 and later interviewed between 1996 and
2000. These twins were volunteered by their
parents, in response to media appeals and
appeals through the Australian school system in
1980–1982 (see Heath et al. 2001; Knopik et al.
2004 for further details of this sample).
Participants were interviewed independently by
telephone using structured diagnostic assess-
ments for DSM-IV (APA, 1994) nicotine depen-
dence, alcohol dependence, major depression,
panic disorder, and childhood conduct disorder,
as well as non-diagnostic assessments of social
anxiety, suicidality, a screen for bipolar disorder,
and a detailed history of consumption of al-
cohol, cigarettes, and other forms of tobacco,
and illicit drugs. The interview was a modiﬁed
version of the Semi-Structured Assessment on
964 M. L. Pergadia et al.
the Genetics of Alcoholism (SSAGA; Bucholz
et al. 1994) and the smoking section was
modiﬁed from the Composite International
Diagnostic Interview (CIDI; Cottler et al.
1991). Telephone interview data were available
from a total of 6257 individual twins (3454
women and 2803 men; 1496 monozygotic (MZ)
female twins, 1140 MZ male twins, 1136 dizy-
gotic (DZ) female twins, 941 DZ male twins,
and 1544 unlike-sex twins). As is typical of a
volunteer twin sample, the sample contained a
higher proportion of MZ female twins than
would be expected from the natural twinning
ratio. At the time of interview, all respondents
ranged in age from 24–36 years old (mean
age=30). In the present study, analysis was
limited to individuals who had ever tried ciga-
rettes (and had data on smoking progression:
n=5579, 54% female) and twin pairs where
both twins had used cigarettes (and had data on
smoking progression: 557 MZF, 418 MZM, 423
DZF, 333 DZM, and 559 DZ unlike sex pairs).
Measures
Progression beyond experimentation with
cigarettes (smoking progression)
Participants who endorsed ‘trying’ cigarettes (at
least one puﬀ) were asked to further describe
their lifetime smoking behavior as : (1) I have
only smoked one or two times ‘ just to try’ ; (2) I
have only smoked occasionally, never as often
as one day a week for three weeks or more; (3) I
have smoked as often as one or two days a week
(but never more than one or two days a week)
for a period of three weeks or more, or (4) I have
smoked daily, or nearly every day, for a period
of three weeks or more. Smoking progression
was coded as ‘0’ if they endorsed smoking only
one or two times ‘ just to try’ and was coded as
‘1’ if participants reported smoking more than
twice. Never-smokers were not included. Given
the age of the sample (median age 30), and the
relatively low prevalence of late-onset smoking,
we would not expect statistical censoring to be
an issue for analyses.
Quantity smoked
Quantity smoked was coded as ‘0’ for in-
dividuals who reported smoking more than two
times but less than 100 times in their lifetime.
Individuals who reported smoking 100 or more
times were asked in reference to the period of
time when they smoked the most, ‘How many
cigarettes did you smoke on a typical day, on
those days when you smoked?’ Quantity
smoked was coded as ‘1’ if they reported
smoking between 1–10 cigarettes per day (cpd),
‘2 ’ for 11–15 cpd, ‘3’ for 16–19 cpd, ‘4 ’ for
20–25 cpd, and ‘5’ for 26 or more cpd.
Individuals who had only smoked once or twice
were coded as missing on the quantity smoked
variable.
The deﬁnition of quantity smoked used in our
analyses (a 6-level ordinal variable) was deter-
mined by the following criteria (Heath et al.
2002) : (1) the variable must be at least three
levels, and at least two of those levels should
not have structurally missing data on the third
outcome dimension (NW), and (2) the variable
must ﬁt a single dimension liability model
(Eaves & Eysenck, 1980). The quantity smoked
variable detailed above ﬁt these criteria. In all
analyses, individuals who never smoked more
than twice were coded as missing for quantity
smoked.
NW
Individuals who reported smoking at least 100
cigarettes lifetime were asked ‘about problems
[they] might have had in the ﬁrst 24 hours after
[they] stopped or cut down or when [they] were
unable to smoke’. Only 48 out of 3158 smokers
reported never stopping or cutting down on
their smoking for at least 24 hours, and these
individuals were not asked questions concerning
NW and were coded as missing for these items.
The diﬀerent measures of DSM-IV NW con-
sidered were as follows: (1) Participants were
queried as to whether they experienced each of
the eight DSM-IV NW symptoms: irritable or
angry, nervous, restless, trouble concentrating,
decreased heart rate, increased appetite, feel
down or depressed, and trouble sleeping. (2)
Individuals were classiﬁed according to whether
they met criteria for DSM-IV NW using sub-
stance dependence criteria, i.e. endorsement of
four or more of the symptoms within 24 hours
or smoking cigarettes again to relieve or
avoid withdrawal symptoms. (3) Individuals
were classiﬁed by DSM-IV NWS criteria, i.e. the
endorsement of four or more of the NW symp-
toms within 24 hours with impairment (that
is the symptoms caused signiﬁcant distress or
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impairment in social, occupational or other
important area of functioning). Individuals who
reported smoking fewer than 100 times lifetime
were not asked questions related to NW. Thus,
all measures of NW were set to missing for these
individuals in all analyses. The use of 100 or
more cigarettes lifetime is widely used to deﬁne
a lifetime history of adult cigarette smoking
(e.g. CDC, 2005b).
Statistical approach
Prevalence rates for smoking progression,
quantity smoked and each measure associated
with NW were estimated separately for women
and men using SAS software (SAS, 1999). In
order to determine whether the NW items could
be represented by a single latent factor, factor
analyses were also conducted separately for
women and men in SAS (SAS, 1999), Given the
missing data structure inherent in the derived
measures, we computed conditional sample size
estimates across the stages, in order to assess
the availability of adequate numbers in each
response category across the three dimensions.
Wald x2 tests of the signiﬁcance of regression
parameters were generated in STATA (StataCorp,
2003) using the robust variance estimator to
control for non-independence of measures.
Univariate genetic models (Eaves et al. 1978;
Neale et al. 2002) were ﬁtted for each categorical
measure by the method of maximum likelihood,
using the ordinal data option in Mx (Neale et al.
2002) to estimate the proportion of the total
variance in eachmeasure that could be explained
by additive genetic factors (A), environmental
inﬂuences shared by members of a twin pair (C),
and non-shared environmental inﬂuences (E).
For multivariate genetic analyses, we used a
modiﬁcation of a recently developed two-stage
modeling approach (Heath et al. 2002), which is
an extension of earlier modeling methods (e.g.
Kendler et al. 1999), that allows for estimation
of the magnitude of genetic and environmental
correlations between diﬀerent stages of smoking
behaviors, when the earlier stages of smoking
are more clearly deﬁned as multi-category rather
than binary variables. The two-stage modeling
approach was developed to handle a class of
problems where some phenotypes can only be
assessed conditional on values of another
phenotype (e.g. tobacco withdrawal cannot
meaningfully be characterized in individuals
with minimal tobacco exposure). Simply limit-
ing analysis to twin pairs concordant for more
than minimal levels of tobacco exposure would
lead to biased estimates of genetic and environ-
mental parameters if there were overlap between
genetic inﬂuences on exposure, and genetic in-
ﬂuences on outcome. While various somewhat
arbitrary conditions can be imposed to ensure
that a bivariate normal genetic model is ident-
iﬁed when the ﬁrst ‘unconditional ’ dimension
is assessed as a binary variable, these can be
avoided (i.e. the full bivariate normal or multi-
variate normal genetic model estimated) pro-
vided that the unconditional dimension can be
modeled as a multiple-category trait, with non-
missing data on the second dimension for two or
more categories on the ﬁrst dimension. Since the
model is dependent upon normal distribution
theory, this approach does, however, depend
upon ﬁnding an acceptable ﬁt of the ﬁrst
unconditional dimension to a normal liability
(‘multiple threshold’) model. This method thus
allows for more accurate estimation of genetic
and environmental correlations, in part because
persons missing in one dimension (e.g. exper-
imenters and occasional smokers who have never
smoked are incorporated more systematically
into the model.
For the present study, we extended the two-
stage model to a three-stage trivariate genetic
analysis, including smoking progression (beyond
trying cigarettes), quantity smoked and NW.
Since 89% of respondents reported a history of
cigarette use, limiting analysis to pairs con-
cordant for any cigarette use would not be
expected to seriously bias estimates of eﬀects in
subsequent stages of smoking. Since it was also
not possible to deﬁne a multi-level measure of
smoking progression (beyond experimentation),
we deﬁned this as a binary variable, and ﬁxed to
zero the non-shared environmental correlations
between this variable and the two other smoking
measures, in order to identify the model. Since
estimates of non-shared environmental variance
in twin data are only weakly correlated with esti-
mates of additive genetic and shared environ-
mental variance, we would expect [and have
conﬁrmed by simulation (Heath et al. 2002)]
that this approach will yield estimates of genetic
and shared environmental variances that very
closely approximate those obtained under a
full model when such a model is identiﬁed and
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estimates of genetic correlations that are only
slightly reduced (0.00–0.20; Heath et al. 2002).
For those who progressed beyond experimen-
tation, we deﬁned a second quantity dimension,
which was undeﬁned (and therefore set to
missing) in those who smoked once or twice.
For those who smoked regularly (100 or more
times), we deﬁned a third NW variable, with
experimenters and occasional smokers both set
to missing on this third variable (Fig. 1).
Extension to a quadrivariate four-stage model
was precluded by evidence of heterogeneity of
twin-pair concordance for the earliest stages of
smoking as a function of simultaneous versus
separate smoking initiation (Pergadia et al.
2006), inability to ﬁt a multiple threshold model
to the initiation stage, and limited power to
resolve competing hypotheses about the overlap
of genetic and environmental inﬂuences on in-
itiation versus later stages of smoking. The issue
of power has not been generally appreciated: a
corollary of the very high MZ pair concordance
for any smoking is that there are few discordant
MZ pairs, hence almost no power to determine
whether overlap of familial inﬂuences in in-
itiation (ever use) and later stages of smoking is
due to genetic or shared family environmental
inﬂuences. Genetic and environmental variances
and correlations were estimated by maximum
likelihood using Mx software (Neale et al. 2002)
under a multiple threshold model which
assumes a continuous normal distribution of
liability with distinct thresholds superimposed.
The goodness-of-ﬁt of the full model was com-
pared, by likelihood ratio x2 test, to submodels
which (i) ﬁxed genetic parameters to zero (test-
ing the signiﬁcance of genetic eﬀects), or (ii)
ﬁxed shared environmental parameters to zero
(testing the hypothesis that there is no overall
eﬀect of environmental factors shared by twin
pairs reared together).
RESULTS
Principal factor analyses identiﬁed a single
factor solution in both women and men for the
DSM-IV NW items. Decreased heart rate and
increase in appetite had only modest loadings in
women (0.20, 0.24 respectively) and men (0.26,
0.28). All other item loadings ranged between
0.44–0.67. Table 1 shows the prevalence rates
for smoking progression, quantity smoked, and
DSM-IV NW measures for female and male
twins. Over 80% of men and 77% of women
who tried cigarettes progressed beyond smok-
ing only twice, and the slightly higher rate in
men was signiﬁcant (Wald x21=9.0, p<0.01).
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FIG. 1. Conditional sample size estimates (and percentages) (total n=5579) across smoking progression, quantity smoked and
DSM-IV nicotine withdrawal. cpd, Cigarettes per day.
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cigarettes per day than female twins (Wald x21=
75.3, p<0.001). For the DSM-IV NW symp-
toms prevalence rates ranged from a low of
13.0% for decreased heart rate to a high of
60.2% for restlessness. Rates were equivalent
across women and men, except for depressed
mood which was signiﬁcantly elevated in
women (27.0%) compared tomen (18.7%,Wald
x21=27.0, p<0.001). Subsidiary analyses found
that except for nervousness, rates of all other
reported NW symptoms were also signiﬁcantly
higher in individuals who persisted in smoking
(reported smoking in the last 6 months ; OR
1.2–1.8). Rates for NW (44.2%, 43.0%) and
NWS (17.0%, 14.7%) did not diﬀer across
women and men, respectively. However, rates of
NWS were three times lower than NW. While
over 40% of smokers reported experiencing
four or more symptoms of NW, at some point
in their life when they quit or cut down on
smoking, these symptoms were perceived to
have caused signiﬁcant impairment in only
approximately one-third of these cases.
Conditional sample size estimates across the
stages of smoking progression, quantity smoked
and NW, and corresponding percentages, are
depicted in Fig. 1. For example, there were 79%
(n=4390) of experimenters who reported smok-
ing beyond experimentation. Experimenters
who did not progress in smoking (21%,
n=1189) were missing data on both quantity
smoked and NW. Of those who progressed in
smoking, 28% (n=1231) did not smoke 100 or
more cigarettes lifetime and were missing data
on NW. Of individuals who had data for NW
symptoms, rates of meeting criteria for DSM-IV
nicotine withdraw ranged from 25% in in-
dividuals who smoked 1–10 cpd to 62% in
individuals smoking o26 cpd. Estimates for
NWS were approximately one-third of that for
NW. Phenotypic correlations between quantity
smoked and NW and NWS were 0.44 and 0.43,
respectively, and could be constrained across
males and females (NW: x23=6.4, p=0.09;
NWS: x23=2.5, p=0.47).
Univariate genetic analyses of smoking
progression (conditioned on smoking once or
twice), quantity smoked, and NW measures
(conditioned on smoking 100 or more times),
are shown in Table 2. Included in the table are
standardized maximum-likelihood estimates of
additive genetic (A), shared environmental (C),
and non-shared environmental variances (E)
and their 95% conﬁdence intervals (CI).
Estimates of shared environmental variance
under the full ACE model were in all cases
zero or nearly so. However, for four variables
(nervousness, decreased heart rate, trouble
Table 1. Lifetime prevalence estimates (%) among women and men
Women Men
(n=3026 initiators) (n=2553 initiators)
Smoking progressiona 77.1% 80.6%
Quantity smokedb (n=2331 progressors) (n=2058 progressors)
3–99 times lifetime 28.2% 27.9%
1–10 cigarettes/day 24.8% 15.8%
11–15 cigarettes/day 13.0% 11.7%
16–19 cigarettes/day 9.9% 10.8%
20–25 cigarettes/day 15.7% 19.9%
o26 cigarettes/day 8.4% 13.9%




Concentration problems 27.6% 27.9%
Decreased heart rate 13.0% 15.3%
Increased appetite 54.9% 57.0%
Depressed moodc 27.0% 18.7%
Trouble sleeping 17.0% 19.3%




a Wald x21=9.0, p<0.01; b Wald x21=75.3, p<0.001; c Wald x21=27.0, p<0.001.
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sleeping, and in women only, depressed mood) it
was not possible to discriminate between AE
and CE models, i.e. either A or C could be
dropped, but not both. There were no cases
where inclusion of non-additive genetic eﬀects
signiﬁcantly improved upon the AE model. The
non-shared environmental variance for de-
creased heart rate was very high (91%) and
additive genetic inﬂuence correspondingly low
(9%). For all other withdrawal symptoms,
heritability estimates were intermediate in
magnitude (26–53%). Signiﬁcant heterogeneity
of genetic and environmental parameters across
gender was observed only for a single symptom,
depressed mood (x25=11.9, p=0.04) with higher
heritability observed in males. Importantly,
for the six-level quantity smoked variable, the
multiple threshold gave an adequate ﬁt to the
data (x2116=135.9, p=0.10).
Fig. 2 depicts the best-ﬁtting three-stage
model for genetic and environmental eﬀects on
smoking progression and the conditional
phenotypes of quantity smoked (in those who
smoked once or twice) and NW (in those who
smoked at least 100 times). We were able to
simplify our initial trivariate ACE models, by
constraining parameters to be equal across
gender (x216=23.2, p=0.11), and then ﬁxing
all C parameters to zero (x26=6.4, p=0.38).
Signiﬁcant genetic correlations were found
between: (1) smoking progression (beyond ex-
perimentation) and quantity smoked: r21=0.72
(95% CI 0.60–0.83) ; (2) smoking progression
and NW: r31=0.53 (95% CI 0.26–0.77), and (3)
quantity smoked and NW: r32=0.76 (95% CI
0.64–0.88). Overall, 45.1% of the variance in
risk for NW was found due to genetic factors,
with 19.3% speciﬁc to NW, 13.4% common to
smoking progression, and 12.4% common to
quantity smoked (controlling for smoking pro-
gression). Similar results emerged using DSM-
IV NWS where the 47.4% of the total variance
in NWS due to genetic factors could be decom-
posed into: 23.3% speciﬁc to NWS, 8.6%
common to smoking progression and 15.5%
common to quantity smoked.
DISCUSSION
Several important ﬁndings emerge from our
analyses. Consistent with previous studies
Table 2. Results of univariate genetic analyses :
standardized maximum-likelihood variance esti-
mates (and 95% conﬁdence intervals) for smok-
ing progression, and for conditional measures of
quantity smoked, and of nicotine withdrawal




Smoking progression 61 (35–70) 1 (0–22) 38 (30–47)
Quantity smoked 57 (39–63) 1 (0–15) 42 (37–48)
Withdrawal symptoms
Irritability 43 (6–56) 2 (0–30) 55 (44–68)
Nervousness 36 (0–51) 0 (0–33) 64 (49–84)
Restlessness 35 (6–47) 0 (0–22) 65 (53–78)
Concentration problems 33 (12–46) 0 (0–14) 67 (54–81)
Decreased heart rate 9 (0–35) 0 (0–22) 91 (65–99)
Increased appetite 26 (1–39) 0 (0–18) 74 (61–87)
Depressed mooda
Femalesb 29 (0–48) 0 (0–29) 71 (52–91)
Malesc 53 (14–72) 0 (0–31) 47 (28–69)
Trouble sleeping 33 (0–48) 0 (0–30) 67 (52–84)
Nicotine withdrawal 37 (13–49) 0 (0–17) 63 (51–76)
Nicotine withdrawal syndrome 40 (20–55) 0 (0–12) 60 (45–77)
a Cannot constrain across sex.
b A or C can be dropped in women, but not both.
c A cannot be dropped in men.
rA21 = 0·72 (0·60–0·83) rA32 = 0·76 (0·64–0·88)






















FIG. 2. Three-stage model results for smoking progression, quan-
tity smoked and DSM-IV nicotine withdrawal. Point estimates of
genetic and environmental variances and correlations, and, in par-
entheses, their 95% conﬁdence intervals, are shown.
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(Svikis et al. 1986; Breslau et al. 1992), there was
remarkable consistency across gender in rates of
reporting NW symptoms, and in the magnitude
of correlations of NW with quantity smoked, in
regular smokers, despite men smoking more
heavily. It is possible that average nicotine
exposure may actually be more similar across
gender, given that men are on average larger
and overall body clearance of nicotine is also on
average greater (Zevin & Benowitz, 2000). Only
for a single symptom, depressed mood upon
withdrawal, was a higher prevalence observed in
female than in male regular smokers (27% v.
19%). There was also consistency across gender
in the magnitude of genetic and environmental
inﬂuence on risk of individual withdrawal
symptoms, and on risk of NW or NWS, with
most estimates of intermediate magnitude
(26–43%). The single exception was depressed
mood upon withdrawal, which appeared to have
stronger additive genetic inﬂuences in men
(53%) compared to women (29%), an un-
anticipated ﬁnding for which we do not have an
explanation. While depressed mood upon with-
drawal was associated with a history of major
depression (OR 2.3), this association did not
vary by gender. To our knowledge, this is the
ﬁrst report on the diﬀerential heritability of in-
dividual NW items. Although prevalence rates
were substantially lower for DSM-IV NWS
compared to DSM-IV NW (using substance
dependence criteria) heritability estimates were
similar for both deﬁnitions: 45% for NW and
47% for NWS, and not substantially greater
than the estimates (30–31%) previously re-
ported by Xian and colleagues (2003, 2005)
using summary measures of DIS-based NW in
male veterans. Our ﬁnding that 61% of the total
variance in smoking beyond experimentation
may be due to additive genetic inﬂuences is also
within the range of previous estimates for
regular smoking in adults from the USA and
Australia (Heath et al. 1993), while the estimate
of 57% for quantity smoked is somewhat
lower than the estimate of 85% reported by
Koopmans et al. (1999) in an adolescent/young
adult Dutch twin sample. This diﬀerence might
be due to diﬀerences in the age ranges used in
these two samples, cultural diﬀerences, or dif-
ferences in phenotypic deﬁnition (e.g. they used
a three-level variable). Evidence suggests a
possible candidate gene for quantity smoked
might be the CYP2A6 with 3-hydroxycotinine
as a potential endophenotype (Benowitz et al.
2003).
The phenotypic factor analyses conducted in
this study suggested that decreased heart rate
and increased appetite, when assessed by retro-
spective self-report, show only weak correlation
with other DSM-IV NW symptoms. In the
case of decreased heart rate, genetic analyses
revealed little evidence for familiality. When we
redid analyses (not reported under Results
above), excluding these two items, estimates of
prevalence of NW in regular smokers (39% in
women, 36% in men) and heritability (41%)
changed only slightly.
We presented here the ﬁrst analyses of the
overlaps between genetic inﬂuences on smoking
progression, quantity smoked, andNW.Weused
a hierarchical modeling procedure to examine
the genetic overlap between the conditional
phenotypes of NW (which could be assessed
only in those who had become regular smokers),
quantity smoked (assessed only in those who
had progressed beyond experimentation) and
progression beyond experimentation. A moder-
ate but signiﬁcant genetic correlation between
progression beyond experimentation, and NW
(0.53) was observed, as well as a more pro-
nounced genetic correlation between quantity
smoked and NW (0.76) controlling for pro-
gression. We also found signiﬁcant genetic
variance (19%) that was speciﬁc to risk of NW,
i.e. not explained by factors that also inﬂuenced
progression beyond experimentation or quan-
tity smoked. Results were very similar using the
more severe NWS phenotype. The genetic
overlap that was found between experimen-
tation and withdrawal is important in the
context of dependence syndrome models that
attribute a key role to withdrawal symptoms in
the emergence of dependence. This result raises
the possibility that at least some individuals
become ‘hooked’ or progress to daily smoking
in part because of increased vulnerability to NW
symptoms early in their smoking careers.
Our results suggest that genetic inﬂuences on
quantity smoked per day can account for not
much more than one-half (0.762=58%) of the
genetic variance in NW vulnerability. However,
interpretation of this result is complicated by the
fact that self-report of cigarettes per day is only
an imperfect measure of achieved blood nicotine
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levels (Etter & Perneger, 2001). Thus, we cannot
exclude the possibility that with better (e.g.
biochemical) measures of exposure, a higher
genetic correlation would be found. It remains
possible, however, that even with more perfect
measures of exposure, important genetic diﬀer-
ences in withdrawal risk will be found among
individuals with very similar exposure histories.
There are several limitations to our ﬁndings.
NW was assessed retrospectively. Such retro-
spective self-report assessment is unavoidable
for twin study analyses, since limiting an analy-
sis to pairs concordant for current smoking
would itself introduce biases to estimates of
genetic and environmental eﬀects. Others have
found across two separate 48–96 hours’ absti-
nence periods that self-reported NW symptoms
were reliable (0.60–0.87; Hughes et al. 1984;
Tate et al. 1993), and that observer reports of
NW are signiﬁcantly associated with self-reports
(0.40–0.62; Hughes & Hatsukami, 1986).
Nonetheless, the reliability and validity of
retrospective self-reports of NW remains to be
examined compared to contemporaneous
measures. SomeDSM-IVNW symptoms appear
diﬃcult for individuals to self-report reliably,
such as decreased heart rate (Hughes &
Hatsukami, 1998). Our analyses raise the possi-
bility that NW could be an informative pheno-
type to identify genes associated with cigarette
use and related problems.
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